Altre lingue L&C Bio Co., Ltd

Azioni

A290650

KR7290650001

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
19.650 ^KRW	-1,65%		-4,15%	-32,24%

2023	L&C Bio Co., Ltd (KOSDAQ:A290650) annuncia un riacquisto di azioni per 143.884 azioni.	CI
2023	L&C BIO Co., Ltd autorizza un piano di riacquisto.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	27/03
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	25/03
Plasmapp Co., Ltd. announced that it has received KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	28/12
Plasmapp Co., Ltd. announced that it expects to receive KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	21/12
Tranche Update on L&C Bio Co., Ltd's Equity Buyback Plan announced on November 23, 2023.	08/12
L&C Bio Co., Ltd's Equity Buyback announced on November 23, 2023, has closed with 143,884 shares, representing 0.63% for KRW 4,881 million.	30/11
L&C Bio Co., Ltd announces an Equity Buyback for 143,884 shares.	23/11
L&C BIO Co., Ltd authorizes a Buyback Plan.	23/11
L&C Bio Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Curexo Inc. announced that it has received KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	30/06/22
L&C Bio Co., Ltd announced that it has received KRW 60 billion in funding	29/06/22
L&C Bio Co., Ltd announced that it expects to receive KRW 60 billion in funding	28/06/22
Curexo Inc. announced that it expects to receive KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	23/05/22
NanoFocusRay Co., Ltd. announced that it expects to receive KRW 3.13 billion in funding from L&C Bio Co., Ltd	16/02/22
Netmarble : Skin care kiosk developer lululab secures funding	30/11/20
Lululab Inc. announced that it has received funding from L&C Bio Co., Ltd, Netmarble Corporation, CTK Investment Co., Ltd., Global Medical Research Center and other investors	10/11/20
Tranche Update on L&C BIO Co., LTD's Equity Buyback Plan announced on June 15, 2020.	25/06/20
L&C BIO Co., LTD's Equity Buyback announced on June 15, 2020, has closed with 91,996 shares, representing 1.25% for KRW 9,967.5 million.	24/06/20
L&C BIO Co., LTD announces an Equity Buyback for 91,996 shares.	15/06/20
L&C BIO Co., Ltd authorizes a Buyback Plan.	15/06/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue L&C Bio Co., Ltd

Azioni

A290650

KR7290650001

Altre lingue

Filtri